Skip to Main Content

Paper Details

GC1118, an Anti-EGFR Antibody with a Distinct Binding Epitope and Superior Inhibitory Activity against High-Affinity EGFR Ligands.
Mol Cancer Ther
25
2016
Anti-EGFR Antibody, Binding Epitope, EGF, EGFR, GC1118, N, anti-EGFR, binding epitope, cancer, cetuximab, mCRC, metastatic colorectal cancer, panitumumab, patient, patients, tumor, tumor xenografts
Author NameAffiliation
Kuglae KimCollege of Life Science and Biotechnology, Yonsei University
Yeup YoonInstitute for Refractory Cancer Research, Samsung Medical Center, Republic of Korea. Samsung Biomedical Research Institute, Sungkyunkwan University
Do-Hyun NamInstitute for Refractory Cancer Research, Samsung Medical Center, Republic of Korea. Samsung Biomedical Research Institute, Sungkyunkwan University, Republic of Korea. Samsung Medical Center
Do-Hyun NamInstitute for Refractory Cancer Research, Samsung Medical Center, Republic of Korea. Samsung Biomedical Research Institute, Sungkyunkwan University, Republic of Korea. Samsung Medical Center
Donggeon KimInstitute for Refractory Cancer Research, Samsung Medical Center, Sungkyunkwan University
  • 1 - 5

Datasets

Release 1.2